Dr. James (Jim) Phillips

Chief Excecutive Officer at PAION AG, Managing Director of PAION Deutschland GmbH

Dr. James Phillips is Chief Executive Officer of PAION AG since October 2019 and within the Management Board, he is responsible  inter alia for Licensing, Business Development, Fundraising, Investor Relations and Production.

Dr. James Phillips is a registered physician who also holds an MBA from the City University Business School in London. Previously, he was the Managing Director of Imevax since 2018 and prior to that CEO of Midatech Pharma for five years. In Europe, Dr. Phillips holds a directorship at Herantis Pharma and will continue to act as an advisor to the Board of Imevax. He was President of EUSA Pharma Europe in its key growth phase prior to its sale to Jazz Pharma in 2012 and CEO and founder of Talisker Pharma (founded in 2004 and sold to EUSA Pharma in 2006). Dr. Phillips was also Chairman of Prosonix between 2007 and 2012 prior to its successful sale to Circassia. Before that, Dr. Phillips worked for Johnson & Johnson and Novartis as a senior executive.